Toggle Dropdown
Groups
Announcements
Projects
Welcome guest
Log in
Friends
Loading
Loading...
https://www.kmov.com/2023/10/27/washington-university-trial-studies-antidepressant-fluvoxamine-treatment-long-covid-symptoms/
0
0
Washington University trial studies antidepressant Fluvoxamine as treatment for Long COVID symptoms - KMOV4
10/27/23 at 10:53pm
Organization
KMOV.com
Author
Nathan Vickers
34 words
0
Comments
A clinical trial at the Washington University School of Medicine is studying the impact of an antidepressant on Long COVID symptoms.
Health
Depression
Washington University in St. Louis
Long COVID
Fluvoxamine
Washington University School of Medicine
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...